Physician profile
Daniel John Hering
NPI 1518203512
$6,618.56
in general payments reported to CMS, 2019-2025
18 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,446 · 2022: $1,542 · 2023: $1,293 · 2024: $1,334 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,630.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,778.87 | 2021-2025 | Breztri, Airsupra, Symbicort |
| United Therapeutics Corporation | $973.12 | 2021-2024 | Tyvaso |
| Mylan Specialty L.P. | $589.51 | 2021-2024 | Yupelri |
| Genzyme Corporation | $537.58 | 2021-2025 | |
| Glaxosmithkline, LLC. | $514.12 | 2021-2025 | Nucala |
| Actelion Pharmaceuticals US, INC. | $458.56 | 2022-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $356.25 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.92 | 2021-2024 | Ofev |
| Baxter Healthcare | $298.26 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $204.95 | 2024-2025 | Smartvest |
| Amgen INC. | $199.14 | 2021-2023 | Tezspire |
| Mylan INC. | $126.89 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $74.42 | 2021 | |
| Verona Pharma, INC. | $61.64 | 2025 | Ohtuvayre |
| Insmed, INC. | $52.81 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $29.93 | 2021 | |
| Biocryst US Sales Co., LLC | $21.38 | 2021 | |
| Janssen Biotech, INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.